Ireland should temporarily suspend its Covid Vaccination Campaign with the Oxford/AstraZeneca jab after some reports found blood clotting in vaccinated people, health authorities said.
A statement issued by Ireland’s Deputy Chief Medical Officer, Dr. Ronan Glynn, stated: “Following new information received from the Norwegian Medicines Agency on Saturday evening 13th March and following discussions with the Health Products Regulatory Authority (HPRA), the National Immunisation Advisory Committee (NIAC) has recommended that the administration of COVID-19 Vaccine AstraZeneca be temporarily deferred from this morning, Sunday 14th March.
- Honey: what happens to your body when you eat this popular alternative to sugar
- Lung Cancer: a natural plant-based medicine that can block the spread of Bronchogenic Carcinomas
- New way of cleaning salad and green vegetables could reduce food poisoning and even extend its shelf life – fresh even after 6 days
- Ten Covid symptoms that might look like you have coronavirus – but it’s actually something else
- Do not let your guard down after the vaccination – warns a pediatrician after second dose of the Pfizer-BioNTech vaccine
“This recommendation has been made following a report from the Norwegian Medicines Agency of four new reports of serious blood clotting events in adults after vaccination with COVID-19 vaccine AstraZeneca.
“It has not been concluded that there is any link between the COVID-19 Vaccine AstraZeneca and these cases.
“However, acting on the precautionary principal, and pending receipt of further information, the NIAC has recommended the temporary deferral of the COVID-19 vaccine AstraZeneca vaccination programme in Ireland.
“The NIAC is due to meet again this morning. A further statement will follow thereafter.”
